Developed Through Collaboration with KLATU, Portal Leverages Advanced Web Technologies and Integration with Federal Express™
Lake Forest, Calif., (July 15, 2008) —CryoPort, Inc. a leading supplier of affordable temperature sensitive shipping solutions for the frozen bio-pharmaceutical industry today announced the release of CryoPort Express Portal™ 1.0 to select pharmaceutical and biomedical providers for final validation. The development and release of the portal follows an extensive review of existing solutions in the market and development of the portal using the latest Web. 2.0 standards and on demand cloud computing technologies. The result provides a rich, dynamic and highly interactive user experience as well as a highly secure and scalable architecture capable of supporting the planned growth of the company.
“From a business perspective the design goal for the portal was to provide our customers with a mission critical, time and cost saving shipping solution,” said Peter Berry, CEO of CryoPort. “CryoPort has introduced the industry’s first pay-per-use shipping solution with no up-front costs to the customer. We are backing it up with an equally innovative user interface that greatly simplifies order-entry, automatically schedules multi-leg shipments, creates shipping labels and export documentation, provides real-time end-to-end tracking of the entire cold chain, and generates alarm notification of shipping delays.”
CryoPort’s Express Portal is tightly integrated with the Federal Express data center via a real-time B2B Web Service that enables CryoPort to monitor every step of the shipping process. Order processing, validation and scheduling are completed in real-time as the customer enters the order. Once the shipper enters the FedEx system, the CryoPort system will continuously monitor every step of the shipment through the FedEx operational framework. This unprecedented visibility into real-time shipping status information enhances CryoPort’s ability to detect and remedy shipping delays before they become costly operational exceptions.
About CryoPort, Inc.
CryoPort is commercializing proprietary, technology-driven shipping products for use in the rapidly growing global biotechnology and bio-pharmaceutical cold chain. The products developed by CryoPort are essential components of the infrastructure required for the clinical testing, research and end user deliver of temperature-sensitive medicines and bio-materials in an increasingly complex logistical environment.
About KLATU, LLC
KLATU designs, develops and markets cold-chain monitoring solutions to help companies manage risk, reduce operating costs and streamline operations through proactive management of the status, condition, and location of cold storage assets and other mission critical equipment.
With a focus on the Life Sciences industry, KLATU also leverages its skills and experience by offering custom engineering design and development services to partners who wish to establish new lines of business or enable new service offerings.
KLATU maintains development teams in Oregon, California, Connecticut and India.